Contents

Search


verdinexor (Laverdia-CA1)

Indications: - oral treatment for dogs with lymphoma Dosage: - tabs: 2.5 mg, 10 mg, 50 mg Mechanism of action: - inhibits nuclear export

General

antiviral agent antineoplastic agent (chemotherapeutic agent)

References

  1. FDA News Release. Jan 11, 2021 FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs. https://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-oral-tablet-treat-lymphoma-dogs
  2. Perwitasari O, Johnson S, Yan X et al Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo. J Virol. 2014 Sep 1;88(17):10228-43. PMID: 24965445 Free PMC article.